Lung cancer after treatment for breast cancer

The Lancet Oncology

Volumn 11, Issue 12, 2010, Pages 1184-1192

  Lorigan, Paul ^a   Califano, Raffaele ^a   Faivre Finn, Corinne ^a   Howell, Anthony ^a   Thatcher, Nick ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

AGE DISTRIBUTION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; DISEASE ASSOCIATION; EARLY CANCER; HUMAN; LUNG CANCER; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING;

AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 78649631903     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70056-5     Document Type: Review

References (63)

1. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995, 333:1456-1461.
2. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997, 337:949-955.
3. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005, 97:116-126.
4. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999, 353:1641-1648.
5. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004, 22:4247-4254.
6. Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007, 18:1133-1144.
7. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. Early Breast Cancer Trialists Collaborative Group (EBCTCG).
8. Hoppe RT Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol 1997, 8(suppl 1):115-118.
9. Tucker MA, Coleman CN, Cox RS, et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988, 318:76-81.
10. Kaldor JM, Day NE, Band P, et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 1987, 39:571-585.
11. de Vathaire F, Hawkins M, Campbell S, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 1999, 79:1884-1893.
12. Henry-Amar M Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol 1992, 3(suppl 4):117-128.
13. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002, 20:3484-3494.
14. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
15. Lorigan P, Radford J, Howell A, Thatcher N Lung cancer after treatment for Hodgkin's lymphoma: a systematic review. Lancet Oncol 2005, 6:773-779.
16. Arriagada R, Lê MG, Rochard F, Contesso G Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996, 14:1558-1564.
17. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995, 332:907-911.
18. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 1990, 26:668-670.
19. Deutsch M, Land SR, Begovic M, et al. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 2003, 98:1362-1368.
20. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-1150.
21. Blichert-Toft M, Nielsen M, During M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008, 47:672-681.
22. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002, 347:567-575.
23. Marini G, Murray S, Goldhirsch A, et al. The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group. Ann Oncol 1996, 7:245-250.
24. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
25. Olivotto IA, Truong PT, Chua B Postmastectomy radiation therapy: who needs it?. J Clin Oncol 2004, 22:4237-4239.
26. Fernando SA, Edge SB Evidence and controversies in the use of post-mastectomy radiation. J Natl Compr Canc Netw 2007, 5:331-338.
27. Zablotska LB, Neugut AI Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 2003, 97:1404-1411.
28. Neugut AI, Robinson E, Lee WC, et al. Lung cancer after radiation therapy for breast cancer. Cancer 1993, 71:3054-3057.
29. Travis LB, Curtis RE, Inskip PD, et al. Re: lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1995, 87:60-61.
30. Galper S, Gelman R, Recht A, et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2002, 52:406-414.
31. Rubino C, de Vathaire F, Shamsaldin A, et al. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003, 89:840-846.
32. Roychoudhuri R, Evans H, Robinson D, et al. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004, 91:868-872.
33. Prochazka M, Granath F, Ekbom A, et al. Lung cancer risks in women with previous breast cancer. Eur J Cancer 2002, 38:1520-1525.
34. Kaufman EL, Jacobson JS, Hershman DL, et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 2008, 26:392-398.
35. Obedian E, Fischer DB, Haffty BG Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 2000, 18:2406-2412.
36. Woodward WA, Strom EA, McNeese MD, et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 2003, 57:327-335.
37. Neugut AI, Murray T, Santos J, et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 1994, 73:1615-1620.
38. Fowble B, Hanlon A, Freedman G, et al. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 2001, 51:679-690.
39. Kroman N, Holtveg H, Wohlfahrt J, et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 2004, 100:688-693.
40. Das IJ, Cheng EC, Freedman G, et al. Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. Int J Radiat Oncol Biol Phys 1998, 42:11-19.
41. Berrington de Gonzalez A, Curtis RE, Gilbert E, et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2009, 102:220-226.
42. Inskip PD, Stovall M, Flannery JT Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994, 86:983-988.
43. Boice JD, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992, 326:781-785.
44. Cancer Incidence in Sweden 2007 (accessed June 1, 2010). http://www.socialstyrelsen.se/lists/artikelkatalog/attachments/8715/2008-125-16_200812516_rev2.pdf.
45. Prochazka M, Hall P, Gagliardi G, et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol 2005, 23:7467-7474.
46. Gilbert ES, Stovall M, Gospodarowicz M, et al. Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 2003, 159:161-173.
47. Ford MB, Sigurdson AJ, Petrulis ES, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer 2003, 98:1457-1464.
48. Swerdlow AJ, Schoemaker MJ, Allerton R, et al. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J Clin Oncol 2001, 19:1610-1618.
49. Lichter A, Pierce L Techniques of radiation therapy. Diseases of the breast 2000, 589-598. Lippincott, Williams & Wilkins, Philadelphia. 2nd edn. J.M. Harris, M.E. Lippman, M. Morrow, C.K. Osbourne (Eds.).
50. Pierce LJ Treatment guidelines and techniques in delivery of postmastectomy radiotherapy in management of operable breast cancer. J Natl Cancer Inst Monogr 2001, 30:117-124.
51. Neugut AI, Weinberg MD, Ahsan H, et al. Carcinogenic effects of radiotherapy for breast cancer. Oncology (Williston Park) 1999, 13:1245-1256.
52. Hall EJ, Wuu CS Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56:83-88.
53. Hall EJ, Henry S Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis. Int J Radiat Biol 2004, 80:327-337.
54. Suit H, Goldberg S, Niemierko A, et al. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 2007, 167:12-42.
55. Dörr W, Herrmann T Cancer induction by radiotherapy: dose dependence and spatial relationship to irradiated volume. J Radiol Prot 2002, 22:A117-A121.
56. Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002, 94:182-192.
57. Boivin JF, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995, 87:732-741.
58. van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000, 18:487-497.
59. Foss Abrahamsen A, Andersen A, Nome O, et al. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 2002, 13:1786-1791.
60. Kaldor JM, Day NE, Bell J, et al. Lung cancer following Hodgkin's disease: a case-control study. Int J Cancer 1992, 52:677-681.
61. Massard G, Ducrocq X, Beaufigeau M, et al. Lung cancer following previous extrapulmonary malignancy. Eur J Cardiothorac Surg 2000, 18:524-528.
62. Laurie SA, Kris MG, Portlock CS, et al. The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease. Cancer 2002, 95:119-126.
63. Booton R, Thatcher N Chemotherapy in advanced nonsmall cell lung cancer: indication, intensity, and duration. Curr Opin Oncol 2002, 14:191-198.